| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CNTB
Connect Biopharma Holdings
|
Jun 17, 2026 | BUY |
Strong Buy
+226.3% avg upside
11 analysts
|
$10.00
400.03% Upside
|
· |
|
ABVX
Abivax SA Sponsored ADR
|
Jun 15, 2026 | BUY |
Strong Buy
+20.7% avg upside
15 analysts
|
$150.00
51.35% Upside
|
+1.9% |
|
SYRE
Spyre Therapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
$112.00
26.81% Upside
|
+0.0% |
|
CLYM
Climb Bio
|
Jun 11, 2026 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
$20.00
74.70% Upside
|
· |
|
CGEM
Cullinan Management
|
Jun 10, 2026 | BUY |
Strong Buy
+125.7% avg upside
15 analysts
|
$38.00
152.88% Upside
|
+19.8% |
|
RNAC
Cartesian Therapeutics
|
Jun 09, 2026 | BUY |
Strong Buy
+228.5% avg upside
19 analysts
|
$44.00
356.83% Upside
|
+0.0% |
|
LQDA
Liquidia Technologies
|
Jun 04, 2026 | BUY |
Strong Buy
-28.2% avg upside
15 analysts
|
$59.00
16.98% Downside
|
+8.6% |
|
RZLT
Rezolute
|
Jun 02, 2026 | BUY |
Strong Buy
+122.3% avg upside
13 analysts
|
$6.00
19.62% Upside
|
· |
|
JBIO
Jade Biosciences
|
Jun 01, 2026 | BUY |
Strong Buy
+232.8% avg upside
16 analysts
|
$74.00
339.94% Upside
|
-16.5% |
|
APGE
Apogee Therapeutics
|
May 27, 2026 | BUY |
Strong Buy
+28.7% avg upside
19 analysts
|
$137.00
51.64% Upside
|
+13.7% |
|
INVA
Innoviva
|
May 26, 2026 | BUY |
Buy
+27.2% avg upside
12 analysts
|
$42.00
86.85% Upside
|
-0.2% |
|
OTLK
Outlook Therapeutics
|
May 18, 2026 | HOLD |
Buy
+483.7% avg upside
11 analysts
|
— | +223.1% |
|
AVTX
Avalo Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+265.1% avg upside
19 analysts
|
$58.00
294.47% Upside
|
-17.6% |
|
ORKA
Oruka Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+61.8% avg upside
16 analysts
|
$151.00
108.64% Upside
|
+10.6% |
|
MLTX
MoonLake Immunotherapeutics
|
May 11, 2026 | BUY |
Strong Buy
+51.6% avg upside
20 analysts
|
$30.00
56.11% Upside
|
+1.9% |
|
TVRD
Tvardi Therapeutics
|
May 08, 2026 | BUY |
Buy
+588.1% avg upside
23 analysts
|
$15.00
470.26% Upside
|
-21.1% |
|
TBPH
Theravance Biopharma
|
May 07, 2026 | BUY |
Buy
+12.2% avg upside
18 analysts
|
$21.00
26.66% Upside
|
-1.8% |
|
NKTR
Nektar Therapeutics
|
May 07, 2026 | BUY |
Buy
+16.6% avg upside
25 analysts
|
$178.00
191.98% Upside
|
-26.9% |
|
AKBA
Akebia Therapeutics
|
Apr 06, 2026 | BUY |
Strong Buy
+831.9% avg upside
16 analysts
|
$4.00
273.93% Upside
|
-29.1% |
|
MAZE
Maze Therapeutics, Inc.
|
Mar 25, 2026 | BUY |
Strong Buy
+145.3% avg upside
12 analysts
|
$46.00
79.13% Upside
|
-21.7% |
|
MREO
Mereo Biopharma Group Plc
|
Mar 19, 2026 | BUY |
Strong Buy
+1146.9% avg upside
11 analysts
|
$1.00
223.17% Upside
|
-33.3% |
|
UTHR
United Therapeutics
|
Feb 25, 2026 | HOLD |
Buy
-19.0% avg upside
26 analysts
|
— | +3.1% |
|
ARDX
Ardelyx
|
Feb 20, 2026 | BUY |
Strong Buy
+124.7% avg upside
21 analysts
|
$17.00
180.97% Upside
|
-3.3% |
|
VRDN
Viridian Therapeutics
|
Nov 04, 2025 | BUY |
Strong Buy
+103.6% avg upside
32 analysts
|
$61.00
266.88% Upside
|
-28.6% |
|
PTGX
Protagonist Therapeutics
|
Nov 03, 2025 | BUY |
Strong Buy
-22.1% avg upside
19 analysts
|
$82.00
27.26% Downside
|
+46.7% |
|
VYNE
VYNE Therapeutics
|
Jul 31, 2025 | HOLD |
Strong Buy
+2024.6% avg upside
9 analysts
|
— | +79.2% |
|
RANI
Rani Therapeutics Holdings
|
Mar 31, 2025 | BUY |
Strong Buy
+1114.2% avg upside
10 analysts
|
$14.00
1689.32% Upside
|
-41.3% |
|
ZLDPF
Zealand Pharma
|
Mar 17, 2025 | BUY |
Buy
+93.0% avg upside
11 analysts
|
$163.14
264.50% Upside
|
· |
|
KROS
Keros Therapeutics
|
Dec 12, 2024 | HOLD |
Strong Buy
+139.8% avg upside
21 analysts
|
— | +16.7% |
|
ANAB
AnaptysBio
|
Dec 02, 2024 | HOLD |
Strong Buy
+26.1% avg upside
26 analysts
|
— | +67.8% |
|
ACRS
Aclaris Therapeutics
|
Nov 18, 2024 | BUY |
Strong Buy
+122.9% avg upside
15 analysts
|
$8.00
77.78% Upside
|
-20.7% |
|
AURA
Aura Biosciences Inc
|
Nov 13, 2024 | BUY |
Strong Buy
+234.5% avg upside
9 analysts
|
$24.00
278.62% Upside
|
-46.5% |
|
MTNB
Matinas BioPharma
|
Nov 09, 2023 | BUY |
Buy
+2183.8% avg upside
7 analysts
|
$50.00
8178.08% Upside
|
-94.2% |
|
BIORQ
Biora Therapeutics
|
May 03, 2022 | BUY |
Strong Buy
+269249900.0% avg upside
6 analysts
|
$4.00
3999899.97% Upside
|
· |
|
VKTX
Viking Therapeutics
|
Apr 28, 2021 | BUY |
Strong Buy
+141.1% avg upside
30 analysts
|
$12.00
60.52% Downside
|
-62.0% |
|
ALDX
Aldeyra Therapeutics
|
Apr 27, 2021 | BUY |
Strong Buy
+716.1% avg upside
21 analysts
|
$29.00
1379.50% Upside
|
-77.3% |
|
PLRX
Pliant Therapeutics
|
Apr 20, 2021 | BUY |
Buy
+1820.7% avg upside
21 analysts
|
$51.00
4296.54% Upside
|
-75.7% |
|
WHWK
Whitehawk Therapeutics
|
Dec 09, 2020 | BUY |
Buy
+201.4% avg upside
12 analysts
|
$60.00
1257.44% Upside
|
-27.5% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.